Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Investigation
NEW YORK, NY – May 12, 2026 – Wolf Haldenstein Adler Freeman & Herz LLP announces an investigation of potential securities claims on behalf of shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) (the “Company” or “Curanex”). The investigation concerns whether Curanex and certain officers and/or directors have engaged in securities fraud or other [...]